Company Description

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.

The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).

The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Sintx Technologies, Inc.

Country	United States
Founded	1996
IPO Date	Feb 13, 2014
Industry	Medical Devices
Sector	Healthcare
Employees	32
CEO	Eric Olson

Contact Details

Address: 1885 West 2100 South Salt Lake City, Utah 84119 United States
Phone	801 839 3500
Website	sintx.com

Stock Details

Ticker Symbol	SINT
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001269026
CUSIP Number	829392703
ISIN Number	US8293927039
SIC Code	3841

Key Executives

Name	Position
Eric K. Olson	Chief Executive Officer and Chairman of the Board
Kevin Trask	Chief Financial Officer
Gregg Richard Honigblum	Chief Investment Officer and Director
Ryan Elmore	President
Kevin J. Ontiveros Esq.	Chief Legal Officer
Lisa Marie Del Re	Chief Commercial Officer

Latest SEC Filings

Date	Type	Title
Aug 13, 2026	SCHEDULE 13G	Filing
Aug 13, 2026	8-K	Current Report
Aug 13, 2026	S-3	Registration statement under Securities Act of 1933
Aug 11, 2026	8-K	Current Report
Aug 11, 2026	10-Q	Quarterly Report
Jul 23, 2026	8-K	Current Report
Jul 2, 2026	8-K	Current Report
Jun 30, 2026	EFFECT	Notice of Effectiveness
Jun 25, 2026	S-3	Registration statement under Securities Act of 1933
Jun 9, 2026	SCHEDULE 13G	Filing

View All SEC Filings